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ABSTRACT :  Allergic Rhinitis is typically characterized by sneezing, rhinorrhoea, nasal 
obstruction, nasal, conjunctival & pharyngeal itching and lacrimation all occurring in a temporal 
relation to allergen exposure.  The peak incidence of this disease occurs in childhood and 
adolescence, with most of the cases belonging to the atopic category. 
 
There is a high incidence of patients of allergic rhinitis attending the outdoor sections of Ajmal 
Khan Tibbiya College Hospital.  Many of them are dissatisfied with conventional anti-histaminic 
drugs.  An open study was carried out on 20 such patients aged between 15 to 50 years to evaluate 
the clinical efficacy of a unani pharmacopeal preparation [Itrifal Ustukhudoos] added with cloves 
[qaranfal].  Preliminary clinical study showed promising results. The study is into the next phase in 
which a comparative double-blind trial is being conducted with this combination and Allegra 
(Fexofenadine hydrochloride). 
 
INTRODUCTION 
 
Allergic rhinitis is an inflammatory condition 
of the nose characterized by sneezing, 
rhinorrhoea and nasal obstruction.  Often it 
may be associated with conjunctival and 
pharyngeal itching, lacrimation and sinustitis.  
The disease has a widespread incidence.   
Although commonly seasonal, it can be 
perennial in an environment of chronic 
exposure.  Majority of the cases belong to the 
childhood & adolescent age groups
3,4,6.   
There is a detailed and ample description of 
rhinitis as ‘zukaam’ in the Unani literature.  
This has been described as a condition in 
which the catarrhal matter flows towards the 
nasal cavity.   Hippocrates has described 
zukaam as the ‘nazal’ or catarrhal 
inflammation of the nasal mucosa
5,7.  Yet 
there is no specific description of the allergic 
variety in the Unani literature.   
 
The pathophysiology of this disease is the 
immediate hypersensitivity reaction occurring 
in the nasal mucosa on exposure to variety of 
allergens.  Most of the case have an atopic 
tendency to various collateral allergies like 
eczematous dermatitis, urticaria and/or 
asthma.  Very often, there is a family history 
of such disease also
2,4. 
 
The first step in the diagnosis of this diseases 
involves its differentiation into seasonal & 
perennial varieties.  The diagnosis depends 
largely on the an accurate history of 
occurrence coincident with the pollination 
and/or other identifiable allergens like dust 
mite, animal dander, etc.
3,4. 
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Avoidance of exposure to the offending 
allergen is the most effective means of 
controlling allergic diseases.  The treatment 
given comprises of various drug classes like 
antihistamines, sympathomimetics, topical 
steroids & mast cell stabilizers.   
Immunotherapy, also called as 
hyposensitisation is also used if conservative 
therapy fails
2,4. 
 
In spite of the better understanding of 
hypersensitivity reaction and their mediators, 
and newer specific classes of drugs (like mast 
cell stabilizers), the morbidity from allergic 
rhinitis is not much influenced.  This study 
was carried out, keeping this and a few other 
points, described below, in mind. 
 
MATERIALS AND METHODS 
 
The basic objective of this study was to 
evaluate the therapeutic efficacy of unani 
pharmacopeal preparation Itrifal Ustukhudoos 
plus  Qaranfal (Eugenia coryophyllata) in 
allergic rhinitis.  Some of the motivating 
factors behind this study were as follows: 
 
  A high incidence of patients of this 
disease in our hospital. 
  Dissatisfaction of the patients with the 
conventional antihistaminics. 
  Literature supporting the use of Itrifal 
Ustukhudoos in nazla and zukaam, and 
cloves in various allergies.
5,7 
 
The location of this study was the unani 
outdoor sections of Ajmal Khan Tibbiya 
College Hospital.  Twenty patients of this 
disease were selected for this study on the 
basis of following criteria. 
 
Inclusion Criteria: 
 
  Presence of symptoms like sneezing, 
nasal obstruction and rhinorrhoea. 
  Occurrence of these symptoms in sudden 
attacks and episodes. 
  Positive family history of at least any one 
of the three diseases- allergic rhinitis, 
allergic dermatitis or bronchial asthma. 
  Eosinophilic count>09/cu.mm. 
 
Exclusion Criteria: 
 
  Subjects aged less than 15 years and more 
than 50 years. 
  Patients suffering from concomitant 
diseases like chronic bronchitis, 
pulmonary tuberculosis, vasomotor 
rhinitis and nasal polyposis. 
 
The composition of Itrifal  Ustukhudoos is 
shown in Table No. A
12.  Patients were 
administered 6 gms. of Itrifal  Ustukhudoos 
(prepared by Dawakhana Tibbiya College, 
AMU Aligarh) plus 2 powdered cloves twice 
a day for four consecutive weeks.  Patients 
were also directed to avoid exposure to any 
identifiable aggravating factors like house 
dust and contact with pets. 
 
OBSERVATION AND RESULTS 
 
The clinical and haemotological assessment 
of all the cases was made at weekly intervals.  
The diagnosis of this disease depends mainly 
on accurate history, yet there are many 
investigations describe in textbooks.  Some of 
them are examination of nasal secretions, 
Serum IgE estimation and skin 
hypersensitivity tests.  Due to limited 
resources we had to rely on clinical features, 
physical examination and eosinophilic count. 
 
DISCUSSION AND CONCLUSION 
 
The baseline observations tabulated in Tables 
A & B indicate that 75% of the patients 
belonged to the age-group below 40 years.  It 
was also observed that all the patients had the 
positive family history of allergic disorders.   
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These findings are consistent with the 
descriptions given in the standard unani and 
modern medical textbooks
2,3,4,5,6,7. 
 
In our study, the hallmarks of the disease viz., 
sneezing, rhinorrhoea and nasal obstruction 
were present in all the 20 cases.  There was on 
overall improvement of 50-80% in these 
features.  This effect is most likely because of 
the clearance on nasal passage (of phlegmatic 
secretions) by the effect of halela, balela 
senna   and turbud.  Chebulinic and 
Chebulagic acids present in halela and balela, 
and aloe-emodin, cathartin & sennosides 
present in  senna are the constituents which 
may have produced this effect
9,10.  Linalyl 
acetate present in ustukhudoos i s  a l s o  a n  
active constituent.  That’s why ustukhudoos is 
called as “broom of the brain”
8,11. 
 
Similarly 18 patients suffered from itching of 
nasal cavity, pharynx and eyes.  There was an 
improvement of 72.23% which is most likely 
because of the clearance of phlegmatic matter.  
An improvement of 44.45% observed in nasal 
mucosal redness is most likely consequent to 
the anti-inflammatory effect of bioflavonoid 
present in kishmish and maveez 
9,10. 
 
The mean eosinophil count which was 10.6 at 
the start of the study showed an improvement 
percentage of 30%.  This effect can be 
attributed to ß-caryophyllene and eugenol 
acetate present in  qarangal
1. 
 
It may thus be concluded from this study that 
out combination of drugs resulted in the 
significant improvement (Table-F) in the 
overall clinical picture of allergic rhinitis.   
This study was quite limited in the first phase; 
however, subsequent studies are underway 
with an increased sample size. 
 
Table – A 
Showing Constituents of Itrifal Ustukhudoos 
S.No. Constituents  Part  Used  Proportion 
1  Halaila Zard (Terminalia chebula)  Bark  2 Parts 
2  Halaila Siyah (Terminalia chebula)  Bark  2 Parts 
3  Balela (Terminalia bellerica) Bark  2  Parts 
4 Amla  (Emblica  officinalis) Fruit  2  Parts 
5  Ustukhdoos (Lavendula stoechas)  Whole Plant  3 Parts 
6  Senna (Cassia augustifolia)  Leaves  2 Parts 
7 Turbud  Sufaid  (Ipomoea  Turpethum) Root  2  Parts 
8  Bisfayaj (Polypodium vulgare)  Root  2 Parts 
9  Mastagi (Pistachia lentiscum) Gum  2  Parts 
10  Aftemoon (Cuscuta chinensis)  Whole Plant  2 Parts 
11  Kishmish (Vitis vinifera)  Fruit  2 Parts 
12  Munaqa (Vitis vinifera)  Fruit  2 Parts 
13  Shahad khalis (Pure Honey)  -  75 Parts 
Pages 152 - 159  4
 
 
 
TABLE – B 
Showing age & Sex distribution 
Total patients = 20 
 
                      Age                                                                             Sex 
Age 
Groups 
Male Female 
(in years) 
No. of 
Cases 
% age 
No. of 
cases 
% age  No. of 
cases 
% age 
16  –  21  7 35.00 4 57.14 3  42.85 
22 – 27  3  15.00  3  100.00  0  0 
28  –  33  3 15.00 2 66.67 1  33.33 
34  –  39  2 10.00 1 50.00 1  50.00 
40  –  45  5 25.00 2 40.00 3  60.00 
Total 20  100.00  12 62.77  8  37.23 
 
 
Table – C 
Showing family history in the patients 
 
Disease  No. of patients  % age 
Bronchial Asthma  9  45.00 
Allergic Dermatitis  6  30.00 
Allergic Rhinits  5  25.00 
Total 20  100.00 
 
Pages 152 - 159  5
Table – D 
Showing effect of drug on incidence of symptoms & signs 
 
During & After Treatment  Before Treatment 
(O Days)   7 Days  14 Days  21 Days  28 Days 
S. 
N
o. 
Symptoms & 
Signs 
No. of 
patients 
% age  No. of 
patients 
Improvement 
% age 
No. of 
patients 
Improvement  
% age 
No. of 
patients 
Improvement  
% age 
No. of 
patients 
Improvement  
% age 
1  Rhinorrohoea  20  100.00  20 0.00 15  25.00 12  40.00 10  50.00 
2  Nasal  Obstr.  20  100.00  18  10.00  13  35.00 9  55.00 6  70.00 
3  Sneezing 20  100.00  16  20.00  10  50.00 8  60.00 4  80.00 
4 Pruritus  of 
Nasal cavity 
& pharynx 
18 90.00 14 
 
13 
22.23 
 
18.75 
12 
 
11 
33.33 
 
31.25 
9 
 
8 
50.00 
 
50.00 
5 
 
4 
72.23 
 
75.00 
5  Lacrimation  16  80.00  18 0.00 16  11.11 13  27.78 10  44.45 
6 Nasal 
Mucosal 
Redness 
18  90.00              
7 Conjunctiveal 
Inflammation 
10  50.00  8  20.00  6  40.00 5  50.00 2  80.00 
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Table – E 
Showing the effect of Drug on Eosinophil Count 
 
Before 
Tt. 
During & after treatment 
(O Day)  7 Days  14 Days  21 Days  28 Days 
 Mean 
Eosino.Count 
Improv. 
% age 
Mean 
Eosino.Count
Improv. 
% age 
Mean 
Eosino.Count
Improv. 
% age 
Mean 
Eosino.Count
Improv. 
% age 
10.60 9.8 7.55 9.4  11.32 8.2 22.64 7.0 30.00 
 
 
Table – F 
Showing the most likely constituents responsible for the improvement in the Clinical Picture 
 
S. No.  CI. Features / BI. Picture Improv.  %  age Constituents Responsible (Most likely) 
1 
2 
3 
 
Rhinorrhoea 
Nasal Obstruction 
Sneezing 
 
50.00 
80.00 
70.00 
Halela & Balela – Chebulinic acid 
                               Chebulaginic acid 
Senna – Aloe-emodin, cathartin, sennosides 
Ustukhdoos – Linalyl acetate 
 
4 
 
Nasal mucosal redness 
 
44.45 
 
Kishmish       Bioflavonoids (Anti-     
Munaqqa       inflammatory effect) 
 
5  Increased Eosinophil Count  30.00  Qaranfal – β-caryophyllene, Eugenol & 
Eugenol acetate (anti-allergic effect) 
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